Angiotensin-converting enzyme 2 protects from severe acute lung failure-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Published:2005-07 Issue:7047 Volume:436 Page:112-116
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Imai Yumiko,Kuba Keiji,Rao Shuan,Huan Yi,Guo Feng,Guan Bin,Yang Peng,Sarao Renu,Wada Teiji,Leong-Poi Howard,Crackower Michael A.,Fukamizu Akiyoshi,Hui Chi-Chung,Hein Lutz,Uhlig Stefan,Slutsky Arthur S.,Jiang Chengyu,Penninger Josef M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature03712.pdf

Reference30 articles.

1. Hudson, L. D., Milberg, J. A., Anardi, D. & Maunder, R. J. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151, 293–301 (1995)

2. Ware, L. B. & Matthay, M. A. The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334–1349 (2000)

3. Vincent, J. L., Sakr, Y. & Ranieri, V. M. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit. Care Med. 31 (suppl.), S296–S299 (2003)

4. Ksiazek, T. G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953–1966 (2003)

5. Drosten, C. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967–1976 (2003)

Cited by 2160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of an engineered ACE2 protein for its improved biological features and its transduction into MSCs: A novel approach to combat COVID-19 infection;International Journal of Biological Macromolecules;2024-10

2. Role of vitamin D in COVID-19 and other viral infections;World Journal of Virology;2024-09-25

3. Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection;Molecular Biotechnology;2024-09-13

4. Angiotensin-(1–7) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1–2 randomized clinical trial;Annals of Intensive Care;2024-09-04

5. Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation;Molecular Therapy - Methods & Clinical Development;2024-09